ARQT · Arcutis Biotherapeutics, Inc.
$26.19
+0.36 (+1.39%)
At close · Aug 14
Market Cap
$3.29B
Shares
125.69M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-05 | Arcutis Biotherapeutics, Inc. Q2 2026 Earnings Conference Call | Earnings call |
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-06 | Arcutis Biotherapeutics, Inc. Q1 2026 Earnings Conference Call | Earnings call |
| 2026-04-14 | 25th Annual Needham Virtual Healthcare Conference | Conference |
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-25 | Arcutis Biotherapeutics, Inc. Q4/FY 2025 Earnings Conference Call | Earnings call |
| 2026-02-11 | Guggenheim Emerging Outlook: Biotech Summit | Event |
| 2025-11-12 | TD Cowen Immunology & Inflammation Summit | Event |
| 2025-11-11 | Guggenheim’s 2nd Annual Healthcare Innovation Conference | Conference |
| 2025-10-28 | Arcutis Virtual Investor Day and Third Quarter 2025 Earnings Conference Call | Earnings call |
| 2025-08-06 | Arcutis Biotherapeutics, Inc. Q2 2025 Earnings Conference Call | Earnings call |
Source: https://investors.arcutis.com/
Key facts
CIK
1787306
CUSIP
03969K108
13F (30d)
269 filings
261 filers
Visit website
Investor relations